In order to provide complete functionality, this web site needs your explicit consent to store browser cookies. If you don't allow cookies, you may not be able to use certain features of the web site including but not limited to: log in, buy products, see personalized content, switch between site cultures. It is recommended that you allow all cookies.

High Risk Medicines Survey

Action Plan to Reduce Prevalence of High Risk Medicines Use​

Safe supply of Valproate Medication​

Valproate in children, young people and adults: summary of NICE guidance and safety advice

High Risk Medicines Data Collection Sheet Safe Dispensing Indicators - April 2019 and October 2019 prescriptions

High Risk Medicines Data Collection Sheet Medicines Optimisation Indicators July 2019 and January 2020 Prescriptions

NECAF Screenshot for High Risk Medicines Survey Indicators 1 to 5 – Safer Dispensing Indicators”

NECAF Screenshot for High Risk Medicines Survey indicators 6 to 9 – Medicines Optimisation Indicators

CPW would like to remind contractors that they should consider their professional obligations in respect of patients who are identified as part of the High Risk Medicines Survey and would encourage pharmacists to talk to these patients (potentially as part of a Medicines Use Review) and make appropriate records in respect of these consultations. Contractors are also reminded that the High risk Medicines survey is also one of the topics included in the collaborative working scheme.